Pfizer
-
Covid-19: Pfizer vaccine expected soon, likely to be available for children too, says AIIMS chief
Scroll Staff
-
Talks on with Pfizer, J&J, Moderna for local manufacturing of Covid vaccines, says foreign secretary
Scroll Staff
-
Serum Institute seeks protection from legal liability, says ‘rules should be same for everyone’
Scroll Staff
-
A simple pill to beat Covid-19? It sounds too good to be true, but Pfizer is giving it a go
Peter Wark, The Conversation
-
Coronavirus: India eases norms for clearing foreign-made vaccines, Pfizer, Cipla likely to benefit
Scroll Staff
-
Mixing and matching Covid-19 vaccines may not be such a bad idea after all
Fiona Russell, The Conversation John Hart, The Conversation
-
Covid-19: In talks with Pfizer, other companies since mid-2020 for import of vaccines, says Centre
Scroll Staff
-
Top 10 coronavirus updates: India on downswing of second wave, says Centre
Scroll Staff
-
As Pfizer seeks approval in India, Kejriwal calls for swift procurement of children’s vaccine
Scroll Staff
-
Covid: Pfizer seeks faster approval, tells India its vaccine ‘highly effective’ on dominant variant
Scroll Staff
-
Coronavirus: All 400 vaccination centres for 18-44 age group in Delhi shut down, says deputy CM
Scroll Staff
-
In discussions about Covid-19 vaccine patent waivers, social utility factors should be prioritised
Deepanshu Mohan
-
Coronavirus: US authorises Pfizer vaccine for use in 12-15 year olds
Scroll Staff
-
‘Vaccine not registered in India although application was submitted months ago’: Pfizer CEO
Scroll Staff
-
Pfizer in talks with India for expedited approval of Covid vaccine
Scroll Staff
-
Coronavirus: Pfizer will supply vaccine doses only through government channels
Scroll Staff
-
Coronavirus: Third vaccine dose likely needed within a year of receiving both shots, says Pfizer CEO
Scroll Staff
-
India is producing less than half of the 1 crore Covid-19 vaccine doses it needs every day
Govindraj Ethiraj, IndiaSpend.com
-
Coronavirus: Pfizer-BioNTech vaccine is 100% effective in 12 to 15 year olds, say companies
Scroll Staff
-
All your questions about the Oxford-AstraZeneca vaccine answered
Sarah Pitt, The Conversation